NextGen Omics & Spatial Biology US 2025

14/11/24 - The Blood Biomarker Challenge hopes to ‘revolutionize dementia diagnosis in the UK’ through a collaborative pilot of blood tests in the NHS.

Overview NGS, Clinical Omics & Diagnostics Single Cell Analysis Spatial Multi-Omics

Explore NextGen Omics & Spatial Biology US 2025: Advancing Therapeutic Innovation Through Multi-Omics Research

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology.

NGS, Clinical Omics & Diagnostics

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through Next Generation Sequencing & Clinical Diagnostics, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

Over 600 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
Over 50 presentations focussed on the critical issues in NGS implementation and data integration
Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets
Discuss digital PCR & liquid biopsies. Hear from key opinion leaders’ in-depth presentations on PCR machines for NGS library preparation, developing nextgen MRD assays and advances in analysing cell-free DNA & CTCs

Agenda at a Glance

Day One | Track 1: Advanced Sequencing Technologies
Day One | Track 2: Multi Omics Data Harmonization, Integration & Analysis
Day One | Track 3: Digital PCR & Liquid Biopsies
Day Two | Track 1: Novel Diagnostics For Infectious & Non-Infectious Disease
Day Two | Track 2: Applying Multi-Omics in the Clinic

Single Cell Analysis

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join Single Cell Analysis to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery
Advance your understanding emerging single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics updates

Agenda at a Glance

Day One | Track 4: Emerging Single Cell Technologies
Day Two | Track 3: Bioinformatics For Single Cell Analysis
Day Two | Track 4: Applications Of Single Cell Technologies

Spatial Multi-Omics

Unlocking the Potential of Spatial Technologies

Spatial Multi Omics are transforming drug development, allowing researchers to more precisely understand biological systems than ever before. At Spatial US, experts from across leading academic institutions and biopharma organizations showcase the most transformative spatial tools and their applications in target identification, biomarker discovery, translational research & clinical design. From data analytics to successful therapeutic case studies, it equips you with the information you need to successfully adopt spatial technologies into your workflows.

Hear from and meet with the key innovators in spatial multi-omics. 2024 attendees included: Distinguished University Professor, George Mason University; Senior Scientist, AbbVie; Principal Scientist, Boehringer Ingelheim
New to 2025! Gain invaluable insights into novel multi-omics technologies for spatial genomics & transcriptomics. Presentations will include translating spatial imaging techniques & approaches into drug development multi-modality processing and spatial transcriptomic databases
New to 2025! Discuss spatial biology for oncology, immunology and neuroscience. Hear from expert speakers discussing the tumour environment, distribution of immune cells within the tumour and mapping cellular diversity in the brain
New to 2025! Advance your understanding on novel multi-omics technologies for spatial proteomics & metabolomics: from developing novel technologies for protein analysis through to automated multi-omics workflows, spatial distribution of proteins within cell and distribution of metabolites at spatial resolution
Join a series of workshops, panel discussions & roundtables. Discussion sessions will include: ‘Overcoming the Challenges of Spatial Data Analysis’

Agenda at a Glance

Day One | Track 5: Novel Multi-Omic Technologies: Spatial Genomics & Transcriptomics
Day One | Track 6: Spatial Biology for Therapeutic Discovery & Development
Day Two | Track 5: Novel Multi-Omic Technologies: Spatial Proteomics & Metabolomics
Day Two | Track 6: Spatial Biology for Therapeutic Discovery & Development

Advancing Therapeutic Innovation Through Multi-Omics Research

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics.

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology.

Networking & knowledge-sharing is at the heart of what we do, with 62 hours of pre-arranged 1-2-1 meetings and over 11 hours of networking solutions don't miss the opportunity to connect with 1000 leaders from across pharma, biotech, regulatory and academia.

Engaging Thought Leadership
Experience a variety of interactive discussions, thought leadership debated, & collaborative roundtables, with insights from industry leaders on key developments and pain points in the advancement of multi-omics.

Global Technology Showcase
An international exhibition showcasing cutting-edge technologies & services from premier providers in the scientific field.

Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections.

1000

leading pharma, biotech, regulatory & academic delegates

700

pre-arranged 1-2-1 meetings, facilitating business growth

hours of presentations, discussions & interactive content

hours of networking breaks, including fireside chats & refreshments

NGS, CLINICAL OMICS & DIAGNOSTICS
Panel Discussion: Overcoming Multi-Omics Data Harmonisation & Analysis Challenges

Moderator: Ruslan Sadreyev, Director of Bioinformatics & Assistant Professor, Massachusetts General Hospital
Panellists: Aridaman Pandit, Senior Principal Research Scientist, Abbvie; Felix Francis, Sr. Manager, Data Management and Analytics Technology Lead, Takeda; Luca Pinello, Associate Professor of Pathology, Harvard Medical School

NGS, CLINICAL OMICS & DIAGNOSTICS
Presentation: An Update On Global Genomics & Diagnostics Policy

Presented by: Virginia Acha, AVP Global Regulatory Policy & Intelligence, MSD

SINGLE CELL
Panel Discussion: Single Cell Multi-Omics Integration – From The Pharma Perspective

Panellists: Tao Yang, Director of Computational Biology, Eli Lilly

SPATIAL MULTI-OMICS
Roundtable Discussion: Safety Biomarkers in the age of Spatial Biology

Moderator: Marina Bleck, Principal Scientist, Boehringer Ingelheim

SPATIAL MULTI-OMICS
Workshop: Spatial Genomics & Transcriptomics to Investigate Tumor Biology Chronic Disease Immunotherapies?

Two presentations followed by a panel discussion with insights from Yasser Riazalhosseini, Associate Professor & Head of Cancer Genomics, McGill University
Stephen Wong, Department Chair & Centre Director Houston Methodist Hospital, Professor at Cornell Medical College

Aleksandra Markovets

Director,

AstraZeneca

Alina Ainbinder

Principal Scientist,

Takeda

Angela Hadjipanayis

Global Director of High Content Data Generation,

Sanofi

Deidre Dalmas Wilk

Director,

GSK

Jasmine Plummer

Director,

St. Jude Children's Research Hospital

Jia-Ren Lin

Director,

LSP, Harvard Medical School

Mike Makrigiorgos

Professor and Director, Medical Physics and Biophysics,

Dana-Farber Cancer Institute

Pascaline Mary

Senior Director,

Hi-Fi Bio

Ruslan Sadreyev

Director of Bioinformatics,

Massachusetts General Hospital

Shoh Asano

Senior Principal Scientist,

Pfizer

Virginia Acha

Associate Vice President, Global Regulatory Policy, MRL,

MSD

Yuchun Guo

Associate Director, Computational Biology and Machine Learning,

CAMP4 Therapeutic

Alexandra Tsolias

Scientist II,

Voyager Therapeutics

Ali Herman

Investigator,

National Institutes of Health

Alice Wan

Senior Scientist,

Abbvie

Anka Ehrhardt

Director,

Merck

Aridaman Pandit

Senior Principal Scientist,

AbbVie

Brian Cunningham

Professor,

University of Illinios

Colles Price

Principal Scientist,

Takeda

Dongdong Lin

Scientist,

EMD Serono

Elsa Molina

Director, Single-Cell & Spatial Omics,

Salk Institute

Eugean Jiwanmall

Senior Research Analyst - Medical Policy & Technology Evaluation,

Independence Blue Cross

Felix Francis

Senior Manager Data Management and Analytics,

Takeda

Gabor Balazsi

Professor,

Stony Brook University

Gang Wu

Director, Center for Applied Bioinformatics,

St Jude Children's Research Hospital

Giorgio Gaglia

Head of Systems Biology, Precision Medicine & Computational Biology,

Sanofi

Guolin Zhang

Principal Scientist,

Sensei Therapeutics

Jan Schejbal

Senior Scientist I,

AbbVie

Joann Arce

Assistant Professor of Paediatrics,

Harvard Medical School

Jun Wang

Associate Professor,

Stony Brook University

Kalina Hristova

Professor of Materials Science & Engineering Institute for NanoBioTechnology,

Johns Hopkins University

Kalpana Pillai

Technical Development Principle Scientist,

Hoffmann La Roche Ltd

Keri Martinowich

Associate Professor and Lead Investigator,

Lieber Institute for Brain Development

Kieran Campbell

Assistant Professor & Research Group Lead,

University of Toronto & Lunenfeld-Tanenbaum Research Institute

Kimberly Smythe

Staff Scientist,

Fred Hutchinson Cancer Center

Leonora Balaj

Assistant Professor,

Massachusetts General Hospital

Lin Wu

Director, Genome Modification Facility,

Harvard University

Luca Pinello

Associate Professor of Pathology,

HARVARD MEDICAL SCHOOL

Marina Bleck

Principal Scientist,

Boehringer Ingelheim Pharmaceuticals, Inc.

Maxime Dhainaut

Director of Functional Genomics,

Noetik

Nikolai Slavov

Professor,

Northeastern University

Priya Chockalingam

Vice President, Head of Clinical Bioanalytics & Translational Sciences,

Beam Therapeutics

Priyank Patel

Senior Scientist,

Boehringer Ingelheim RCV GmbH & Co KG

Rajib Schubert

Clinical Development Lead,

Roche

Ricardo de Matos Simoes

Instructor,

DFCI

Sammy Ferri-Borgogno

Instructor,

MD Anderson Cancer Center

Shuqiang Li

Lead Scientist, Translational Immunogenomic Laboratory,

Dana-Farber Cancer Institute

Simona Cristea

Head of Data Science,

DFCI

Sourav Choudhury

Lab Head,

Sanofi

Tao Yang

Director of Computational Biology,

Eli Lilly

Theodore Perkins

Senior Scientist,

Ottawa Health Research Institute

Tien Phan-Everson

Scientist II,

Allen Institute for Immunology

Troy McEachron

Principal Investigator,

National Institutes of Health

Wardiya Afshar Saber

Research Fellow,

Boston Children's Hospital

Wenning Qin

Senior Vice President Innovation,

eGenesis

Winston Hide

Associate Professor,

Beth Israel Deaconess Medical Center / Harvard Medical School

Xiang Chen

Associate Member,

St Jude Children's Research Hospital

Yan Tang

Principal Investigator,

Brigham & Women’s Hospital

Yasser Riazalhosseini

Associate Professor,

McGill University

Young Don Kwak

Principal Scientist ll,

Novartis

Yu-Chi Chen

Scientist,

NCATS/National Institutes of Health

Yu-Hwa Lo

Professor,

University of California, San Diego

Zongmei Gao

Senior Scientist,

Abbvie

Zora Modrusan

Sr. Director NGS,

Genentech

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

In-Person Services Digital Marketing Services

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Find Out More

Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs.

Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.

We offer two options starting from $1990, based on the size of your organisation. To get involved, apply today and our Start-Up Lead will be in touch to discuss further.

Criteria:

The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.

To be eligible for inclusion, you must meet the following criteria:

• 0 – 5 years operating
• 0 – 30 employees
• Pre-Series A funding

Successful applicants will receive as part of their package:

• 1 full conference pass
• 10-minute pitch on the Start-Up Stage
• 1x1m space in Start-Up Zone: cocktail table provided, start-up to bring 1x pull-up banner
• Logo featured on website & event platform as a participating start-up
• Ability to arrange 1:1 meetings via to the congress app

The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.

Please submit your poster presentation by no later than 13^th January 2025 in the below category:

Protein/Antibody Engineering
Bioanalysis & Characterisation
Next Generation Biotherapeutics
Peptides Chemistry & Therapeutics
Oligonucleotides Chemistry & Therapeutics
Sustainable Chemistry & Manufacturing

Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13^th January 2025
ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows:

Register and submit an abstract by 13^th January 2025 using the registration link to the left on this page
Once registered you will be provided with the online abstract submission form
Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event
The winners’ 10-minute oral presentations will take place during the networking drinks on day 2

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights.

"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."

Chief Business Officer
Scipio Bio

"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."

Senior Product Marketing Manager
Levitasbio

"NextGen Omics US was well organised, with highly relevant and enaged attendees."

Senior Sales Specalist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences^® – A Bruker Company

"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."

Regional Oncogenomic Liaison
Exact Sciences

"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"

Digital Marketing Manager
Allumiqs

Sheraton Boston Hotel

39 Dalton Street, Boston, Massachusetts, USA, 02199

Directions

By Air – Boston Logan International Airport – Sheraton Boston Hotel is 4 miles from the International Airport. A single taxi ride to the hotel will cost approx. $26-$35 and will take around 11 minutes. Additionally, you could get subway from Prudential- Government Center then to Airport.
By Bus - The closest bus stop to the venue is Boylston Street, which is a 5min walk away. If you’re wanting to get to South Station Train Terminal you will need to walk to Stuart St and dismount at Lincoln St, a short 2 minute walk you will find the station.
Parking – There is self-parking available (garage parking) at the hotel for $30 (this may be subject to state local taxes). There is no valet parking at this venue. For further information please contact the hotel directly.
Subway/Tram – The closest subway/tram stop to the venue is Prudential, which is a 3min walk away. If you’re wanting to get to South Station Train Terminal you will need to walk to Prudential get the E tram change over at Park Street on the Red line to South Station.

More information on accommodation coming soon

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of NextGen Omics & Spatial Biology US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Visit Venue Website

In-Person & Online Events

Online Activities

20/11/24 - Single Cell Analysis in Pharmaceutical Drug Discovery & Development

13/01/25 - Regulatory developments for biomarker research

10/04/25 - Sartorius Webinar

About

Community

Media Partners

In-Person Services

Digital Marketing Services

Browse All Resources

Latest Resources

Alzheimer's Society Continue £5m Blood Biomarker Challenge for Dementia Blood Tests on NHS

Featured Resource

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

March 27 - 28, 2025 | Boston, MA

From Novel Technologies to Clinical Applications:Driving the Next Generation of Multi-Omics Research

NextGen Omics & Spatial Biology US 2025

NGS, Clinical Omics & Diagnostics

Agenda at a Glance

Single Cell Analysis

Agenda at a Glance

Spatial Multi-Omics

Agenda at a Glance

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research

Explore the NextGen Omics & Spatial Biology US 2025 Programme

NextGen Biomed 2025 is supported by our Scientific Programme Partner The Antibody Society

What to Expect at NextGen Omics & Spatial Biology US 2025